CLLassify, Marie Skłodowska-Curie Individual Fellowships 2015
Τhe scientific proposal CLLassify was successfully evaluated within the framework of the European Actions Marie Skłodowska-Curie Individual Fellowships IF-EF (MSCA-IF-2015-EF).
The proposal with full name “Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia” was submitted by the Postdoctoral Researcher, Dr. Theodoros Moysiadis (fellow), under the supervision of the Director of the INAB, Dr. Kostas Stamatopoulos (Supervisor-Coordinator). The funding of the program refers to the period 2016-2018. The high evaluation of the proposal reflects both its scientific excellence and the dynamic of INAB in a pan-European level.
CLLassify is a highly innovative project that aspires to face the high-challenging and timely problems related to chronic lymphocytic leukemia, and in particular the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient.